Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Benson

Showing results (251-260 of 271) with videos related to

Pageof 28
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 6, 2004
Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant databaseMichael J Krowka, M Susan Mandell, Michael A E Ramsay, et al.
Mayo Clinic Proceedings|August 14, 2012
Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognitionTerry M Therneau, Robert A Kyle, L Joseph Melton, et al.
Journal of Clinical and Translational Science|July 25, 2022
Changing the face of academic medicine: an equity action plan for institutionsFelicity T Enders, Elizabeth H Golembiewski, Minerva A Orellana, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 9, 2014
A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral densityRobert R Recker, Charles T Benson, Toshio Matsumoto, et al.
Hepatology (Baltimore, Md.)|March 1, 1997
A prognostic model for the outcome of liver transplantation in patients with cholestatic liver diseaseP Ricci, T M Therneau, M Malinchoc, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 25, 2015
The Effect of Discontinuing Treatment With Blosozumab: Follow-up Results of a Phase 2 Randomized Clinical Trial in Postmenopausal Women With Low Bone Mineral DensityChristopher P Recknor, Robert R Recker, Charles T Benson, et al.
Hepatology (Baltimore, Md.)|July 27, 1999
Hepatic retransplantation in cholestatic liver disease: impact of the interval to retransplantation on survival and resource utilizationW R Kim, R H Wiesner, J J Poterucha, et al.
Leukemia|July 12, 2012
Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUSJ A Katzmann, R Clark, R A Kyle, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 29, 2024
Performance of AI-Enabled Electrocardiogram in the Prediction of Metabolic Dysfunction-Associated Steatotic Liver DiseaseProwpanga Udompap, Kan Liu, Itzhak Zachi Attia, et al.
Molecular Metabolism|November 27, 2018
LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of conceptTamer Coskun, Kyle W Sloop, Corina Loghin, et al.
Pageof 28

Showing results (251-260 of 271) with videos related to

Sort By:
Pageof 28
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 6, 2004
Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant databaseMichael J Krowka, M Susan Mandell, Michael A E Ramsay, et al.
Mayo Clinic Proceedings|August 14, 2012
Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognitionTerry M Therneau, Robert A Kyle, L Joseph Melton, et al.
Journal of Clinical and Translational Science|July 25, 2022
Changing the face of academic medicine: an equity action plan for institutionsFelicity T Enders, Elizabeth H Golembiewski, Minerva A Orellana, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 9, 2014
A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral densityRobert R Recker, Charles T Benson, Toshio Matsumoto, et al.
Hepatology (Baltimore, Md.)|March 1, 1997
A prognostic model for the outcome of liver transplantation in patients with cholestatic liver diseaseP Ricci, T M Therneau, M Malinchoc, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 25, 2015
The Effect of Discontinuing Treatment With Blosozumab: Follow-up Results of a Phase 2 Randomized Clinical Trial in Postmenopausal Women With Low Bone Mineral DensityChristopher P Recknor, Robert R Recker, Charles T Benson, et al.
Hepatology (Baltimore, Md.)|July 27, 1999
Hepatic retransplantation in cholestatic liver disease: impact of the interval to retransplantation on survival and resource utilizationW R Kim, R H Wiesner, J J Poterucha, et al.
Leukemia|July 12, 2012
Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUSJ A Katzmann, R Clark, R A Kyle, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 29, 2024
Performance of AI-Enabled Electrocardiogram in the Prediction of Metabolic Dysfunction-Associated Steatotic Liver DiseaseProwpanga Udompap, Kan Liu, Itzhak Zachi Attia, et al.
Molecular Metabolism|November 27, 2018
LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of conceptTamer Coskun, Kyle W Sloop, Corina Loghin, et al.
Pageof 28